CD274 and cancer: Recent studies have identified a wide range of other immune checkpoint molecules beside PD1/PD-L1, which could be suitable for cancer treatment, in particular TIM-3, LAG-3, TIGIT and V-domain Ig suppressor of T cell activation (VISTA).